Clinical trials
Endocarditis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
| Completed | 6 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Wake Forest University Health Sciences | 2 |
| AbbVie | 1 |
| Abbott Medical Devices | 1 |
| Boston Medical Center | 1 |
| Corewell Health East | 1 |
| Daniel Benjamin | 1 |
| Emory University | 1 |
| Henry Ford Health System | 1 |
| Herlev Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocarditis | 18 |
| Bacteremia | 6 |
| Staphylococcal Infections | 3 |
| Arthritis, Infectious | 2 |
| Endocarditis, Bacterial | 2 |
| Gram-Positive Bacterial Infections | 2 |
| Osteomyelitis | 2 |
| Sepsis | 2 |
| Adenoviridae Infections | 1 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.